Cas:68981-86-2 4,4-dimethyl-2-pyridin-3-yl-5H-1,3-oxazole manufacturer & supplier

We serve Chemical Name:4,4-dimethyl-2-pyridin-3-yl-5H-1,3-oxazole CAS:68981-86-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,4-dimethyl-2-pyridin-3-yl-5H-1,3-oxazole

Chemical Name:4,4-dimethyl-2-pyridin-3-yl-5H-1,3-oxazole
CAS.NO:68981-86-2
Synonyms:4,5-Dihydro-4,4-dimethyl-2-(pyrid-3-yl)oxazole;3-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-pyridine;4,5-Dihydro-4,4-dimethyl-2-(3-pyridyl)oxazole;4,4-dimethyl-2-(3-pyridyl)-1,3-oxazoline;3-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)pyridine;4,4-Dimethyl-2-(3-pyridyl)-oxazoline;MFCD01313220
Molecular Formula:C10H12N2O
Molecular Weight:176.21500
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:284.7ºC at 760 mmHg
Density:1.12 g/cm3
Index of Refraction:1.569
PSA:34.48000
Exact Mass:176.09500
LogP:1.07260

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4,5-Dihydro-4,4-dimethyl-2-(pyrid-3-yl)oxazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD01313220 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD01313220 Use and application,4,5-Dihydro-4,4-dimethyl-2-(3-pyridyl)oxazole technical grade,usp/ep/jp grade.


Related News: McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 4-ethyl-1H-pyrrolo[3,2-c]pyridine manufacturers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. Ganoderenic acid C suppliers He also mentioned that derivatives of these APIs and lot of other value-added APIs in the same range will also be manufactured at the new facility. 5,8-dimethyl-1H-quinolin-4-one vendor & factory.